Publication | Closed Access

Nanoparticulate delivery of irinotecan active metabolite (SN38) in murine colorectal carcinoma through conjugation to poly (2-ethyl 2-oxazoline)-b-poly (L-glutamic acid) double hydrophilic copolymer

NanomedicineOncologyPolymer-drug ConjugateMedicineNano-drug DeliveryTumor TargetingDouble Hydrophilic CopolymerDrug Delivery SystemPharmacologyRadiation OncologyIrinotecan Active MetaboliteCancer ResearchNanoparticulate Delivery